A much-awaited advisory group tasked with resolving clinical trial-related issues in the EU that sponsors, regulators and other stakeholders might face is up and running, following the appointment of the group’s second co-chair.
Denis Lacombe, chief executive officer of the European Organisation for Research and Treatment of Cancer (EORTC), was appointed as the...